Developing a new drug from original idea to the launch of a finished product is a complex process that can take upwards of fifteen years and cost more than a billion dollars. To remain competitive, research centers must find ways to streamline early processes to identify molecules that possess suitable characteristics.
Increasingly this means optimizing business processes such as data capture, consolidation and analytics across the drug discovery process. The Pristima XD Operations & Compliance software module supports you with initial target identification and validation, through assay development, high throughput screening, hit identification, lead optimization and finally the selection of a candidate molecule for clinical development.
For preclinical laboratories operating in both GLP and non-GLP environments, Xybion offers an end-to-end solution that begins with data capture, through data consolidation, and aggregation, into data analytics and reporting.
Our cloud-based software suite is uniquely positioned to provide comprehensive business process enablement for today’s global laboratory enterprise, resulting in faster cycle times, reduced IT costs, and increased innovation.
As a fully configurable, laboratory-centric business process management platform, Xybion enables critical business processes in preclinical and early development, such as:
Head of Quality Assurance
Heidi leads Xybion’s Quality Assurance practice. She has over 20 years’ experience in designing and implementing quality assurance policies. Since joining Xybion in 2000, Heidi worked with several clients to design quality policies and ensure compliance. She is responsible to hosting Xybion customer audits. Heidi has a BA degree in Biology from The King’s College.